Exploring Predictive Risk Factors of Infusion Reactions with First Pertuzumab Administration in HER2-positive Breast Cancer Patients: A Single Institution Experience
-
Published:2023
Issue:1
Volume:6
Page:
-
ISSN:2433-3298
-
Container-title:JMA Journal
-
language:en
-
Short-container-title:JMA J
Publisher
Japan Medical Association
Subject
General Medicine,General Chemistry